Developing new drugs for the treatment of ocular diseases can be a time-consuming and costly undertaking. The trip from laboratory to market can take anywhere between 10 to 20 years and will cost
Developing new drugs for the treatment of ocular diseases can be a time-consuming and costly undertaking. The trip from laboratory to market can take anywhere between 10 to 20 years and will cost around US$1 billion.
Fig 1 outlines a breakdown of the 2013 United States Food and Drug Administration